Non-antiepileptic drugs for trigeminal neuralgia (Q24234904)

1

0 references

Muke Zhou

2

0 references

Li He

3

0 references

Ning Chen

Cochrane Database of Systematic Reviews

4

0 references

publication date

19 January 2011

0 references

published in

0 references

cites work

The effect of single-application topical ophthalmic anesthesia in patients with trigeminal neuralgia. A randomized double-blind placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

Pimozide therapy for trigeminal neuralgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

The analgesic effect of tocainide in trigeminal neuralgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

Clomipramine and Amitriptyline in the Treatment of Severe Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

Comparison of L-baclofen and racemic baclofen in trigeminal neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

A clinical and experimental investigation of the effects of tizanidine in trigeminal neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

Sumatriptan alleviates pain in patients with trigeminal neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

Intranasal lidocaine 8% spray for second-division trigeminal neuralgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

A randomized, controlled trial of high-dose dextromethorphan in facial neuralgias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

Comprehensive study of diagnosis and treatment of trigeminal neuralgia secondary to tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

AAN-EFNS guidelines on trigeminal neuralgia management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

Pathophysiology of trigeminal neuralgia: the ignition hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

Core outcome measures for chronic pain clinical trials: IMMPACT recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945-1984.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

Incidence of facial pain in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

Gabapentin supplemented with ropivacain block of trigger points improves pain control and quality of life in trigeminal neuralgia patients when compared with gabapentin alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

Pregabalin for acute and chronic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

Trigeminal neuralgia--pathophysiology, diagnosis and current treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

Impaired trigeminal nociceptive processing in patients with trigeminal neuralgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

Hospitalizations for aplastic anemia and agranulocytosis in Saskatchewan: incidence and associations with antecedent prescription drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

Pharmacotherapy of trigeminal neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

Long-term treatment of trigeminal neuralgia with carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

Carbamazepine for acute and chronic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

Lamotrigine for acute and chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

Tic douloureux in Rochester, Minnesota, 1945-1969

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

Diagnosis and differential diagnosis of trigeminal neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

Long-term cohort study comparing medical (oxcarbazepine) and surgical management of intractable trigeminal neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

7 January 2021

Tizanidine in the management of trigeminal neuralgia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

7 January 2021

Efficacy of pregabalin in the treatment of trigeminal neuralgia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

7 January 2021

Subcutaneous sumatriptan for refractory trigeminal neuralgia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

7 January 2021

Efficacy of baclofen in trigeminal neuralgia and some other painful conditions. A clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

7 January 2021

Trigeminal neuralgia in multiple sclerosis relieved by a prostaglandin E analogue

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004029.PUB3

7 January 2021

Gabapentin for acute and chronic pain

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD005452

Identifiers

DOI

10.1002/14651858.CD004029.PUB3

1 reference

Consolidated OpenCitations Corpus – April 2017

2285762

2285762

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference